Nutt, David J.
Imperial College London
88 papers on CoChatORCID 0000-0002-1286-1401
Most cited papers
- Verified
LSD enhances suggestibility in healthy volunteers
Carhart-Harris, R. L., Kaelen, M., Whalley, M. G., Bolstridge, M., Feilding, A., & Nutt, D. J. (2015) · Psychopharmacology
Psychedelics and Drug StudiesPain Management and Placebo Effect
Cited by 320
- Verified
Neural correlates of the DMT experience assessed with multivariate EEG
Timmermann, C., Roseman, L., Schartner, M., Milliere, R., Williams, L. T. J., Erritzoe, D., Muthukumaraswamy, S., Ashton, M., Bendrioua, A., Kaur, O., et al. (2019) · Scientific Reports
Psychedelics and Drug StudiesParanormal Experiences and Beliefs
Cited by 315
- Verified
British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders: an update
Wilson, S., Anderson, K., Baldwin, D., Dijk, D.-J., Espie, A., Espie, C., Gringras, P., Krystal, A., Nutt, D., Selsick, H., et al. (2019) · Journal of Psychopharmacology
Sleep and related disordersCircadian rhythm and melatonin
Cited by 312
- Verified
LSD‐induced entropic brain activity predicts subsequent personality change
Lebedev, A. V., Kaelen, M., Lövdén, M., Nilsson, J., Feilding, A., Nutt, D. J., & Carhart‐Harris, R. L. (2016) · Human Brain Mapping
Psychedelics and Drug StudiesParanormal Experiences and Beliefs
Cited by 303
- Verified
Ketamine effects on brain GABA and glutamate levels with 1H-MRS: relationship to ketamine-induced psychopathology
Stone, J. M., Dietrich, C., Edden, R., Mehta, M. A., De Simoni, S., Reed, L. J., Krystal, J. H., Nutt, D., & Barker, G. J. (2012) · Molecular Psychiatry
Treatment of Major DepressionSchizophrenia research and treatment
Cited by 295
- Verified
The paradoxical psychological effects of lysergic acid diethylamide LSD
Carhart-Harris, R. L., Kaelen, M., Bolstridge, M., Williams, T. M., Williams, L. T., Underwood, R., Feilding, A., & Nutt, D. J. (2016) · Psychological Medicine
Psychedelics and Drug StudiesParanormal Experiences and Beliefs
Cited by 293
- Verified
Evidence-based guidelines for the pharmacological management of attention deficit hyperactivity disorder: update on recommendations from the British Association for Psychopharmacology
Bolea-Alamañac, B., Nutt, D. J., Adamou, M., Asherson, P., Bazire, S., Coghill, D., Heal, D., Müller, U., Nash, J., Santosh, P., et al. (2014) · Journal of Psychopharmacology
Attention Deficit Hyperactivity DisorderPharmaceutical studies and practices
Cited by 287
- Verified · note
Flumazenil Provocation of Panic Attacks: Evidence for Altered Benzodiazepine Receptor Sensitivity in Panic Disorder
Nutt, D. J. (1990) · Archives of General Psychiatry
Anxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesNeuroscience and Neuropharmacology Research
Cited by 272
- Verified
Effects of psilocybin therapy on personality structure
Erritzoe, D., Roseman, L., Nour, M. M., MacLean, K., Kaelen, M., Nutt, D. J., & Carhart‐Harris, R. L. (2018) · Acta Psychiatrica Scandinavica
Psychedelics and Drug StudiesTreatment of Major Depression
Cited by 267
- Verified
Evidence-based guidelines for management of attention-deficit/hyperactivity disorder in adolescents in transition to adult services and in adults: recommendations from the British Association for Psychopharmacology
Nutt, D. J., Fone, K., Asherson, P., Bramble, D., Hill, P., Matthews, K., Morris, K. A., Santosh, P., Sonuga-Barke, E., Taylor, E., et al. (2007) · Journal of Psychopharmacology
Attention Deficit Hyperactivity DisorderPharmaceutical studies and practices
Cited by 259
- Verified
Default Mode Network Modulation by Psychedelics: A Systematic Review
Gattuso, J. J., Perkins, D., Ruffell, S., Lawrence, A. J., Hoyer, D., Jacobson, L. H., Timmermann, C., Castle, D., Rossell, S. L., Downey, L. A., et al. (2023) · International Journal of Neuropsychopharmacology
Psychedelics and Drug StudiesFunctional Brain Connectivity Studies
Cited by 256
- Verified
Functional Connectivity Measures After Psilocybin Inform a Novel Hypothesis of Early Psychosis
Carhart-Harris, R. L., Leech, R., Erritzoe, D., Williams, T. M., Stone, J. M., Evans, J., Sharp, D. J., Feilding, A., Wise, R. G., & Nutt, D. J. (2013) · Schizophrenia Bulletin
Psychedelics and Drug StudiesFunctional Brain Connectivity Studies
Cited by 256
- Verified
Therapeutic alliance and rapport modulate responses to psilocybin assisted therapy for depression
Murphy, R., Kettner, H., Zeifman, R., Giribaldi, B., Kartner, L., Martell, J., Read, T., Murphy-Beiner, A., Baker-Jones, M., Nutt, D., et al. (2022) · Frontiers in Pharmacology
Psychedelics and Drug StudiesPsychotherapy Techniques and Applications
Cited by 250
- Verified
Benzodiazepines: Risks and Benefits. A Reconsideration
Baldwin, D. S., Aitchison, K., Bateson, A., Curran, H. V., Davies, S., Leonard, B., Nutt, D. J., Stephens, D. N., & Wilson, S. (2013) · Journal of Psychopharmacology
Anxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesPharmaceutical Practices and Patient Outcomes
Cited by 249
- Verified
Defining substance use disorders: do we really need more than heavy use?
Rehm, J., Marmet, S., Anderson, P., Gual, A., Kraus, L., Nutt, D. J., Room, R., Samokhvalov, A. V., Scafato, E., Trapencieris, M., et al. (2013) · Alcohol and Alcoholism
Substance Abuse Treatment and OutcomesGambling Behavior and Treatments
Cited by 242
- Verified
Implications for psychedelic-assisted psychotherapy: functional magnetic resonance imaging study with psilocybin
Carhart-Harris, R. L., Leech, R., Williams, T. M., Erritzoe, D., Abbasi, N., Bargiotas, T., Hobden, P., Sharp, D. J., Evans, J., Feilding, A., et al. (2012) · British Journal of Psychiatry
Psychedelics and Drug StudiesParanormal Experiences and Beliefs
Cited by 237
- Verified
Increased amygdala responses to emotional faces after psilocybin for treatment-resistant depression
Roseman, L., Demetriou, L., Wall, M. B., Nutt, D. J., & Carhart-Harris, R. L. (2018) · Neuropharmacology
Psychedelics and Drug StudiesTreatment of Major Depression
Cited by 230
- Verified
European rating of drug harms
van Amsterdam, J., Nutt, D., Phillips, L., & van den Brink, W. (2015) · Journal of Psychopharmacology
Substance Abuse Treatment and OutcomesCriminal Law and Policy
Cited by 229
- Verified
A Delphi-method-based consensus guideline for definition of treatment-resistant depression for clinical trials
Sforzini, L., Worrell, C., Kose, M., Anderson, I. M., Aouizerate, B., Arolt, V., Bauer, M., Baune, B. T., Blier, P., Cleare, A. J., et al. (2022) · Molecular Psychiatry
Treatment of Major DepressionDelphi Technique in Research
Cited by 214
- Verified
Association of the Anxiogenic and Alerting Effects of Caffeine with ADORA2A and ADORA1 Polymorphisms and Habitual Level of Caffeine Consumption
Rogers, P. J., Hohoff, C., Heatherley, S. V., Mullings, E. L., Maxfield, P. J., Evershed, R. P., Deckert, J., & Nutt, D. J. (2010) · Neuropsychopharmacology
Coffee research and impactsNeurotransmitter Receptor Influence on Behavior
Cited by 212
- Verified
Therapeutic mechanisms of psilocybin: Changes in amygdala and prefrontal functional connectivity during emotional processing after psilocybin for treatment-resistant depression
Mertens, L. J., Wall, M. B., Roseman, L., Demetriou, L., Nutt, D. J., & Carhart-Harris, R. L. (2020) · Journal of Psychopharmacology
Psychedelics and Drug StudiesTreatment of Major Depression
Cited by 208
- Verified
Striatal dopamine D2/D3 receptor binding in pathological gambling is correlated with mood-related impulsivity
Clark, L., Stokes, P. R., Wu, K., Michalczuk, R., Benecke, A., Watson, B. J., Egerton, A., Piccini, P., Nutt, D. J., Bowden-Jones, H., et al. (2012) · NeuroImage
Gambling Behavior and TreatmentsNeurotransmitter Receptor Influence on Behavior
Cited by 193
- Verified
Self-blinding citizen science to explore psychedelic microdosing
Szigeti, B., Kartner, L., Blemings, A., Rosas, F., Feilding, A., Nutt, D. J., Carhart-Harris, R. L., & Erritzoe, D. (2021) · eLife
Psychedelics and Drug StudiesPain Management and Placebo Effect
Cited by 192
- Verified
Stratified medicine for mental disorders
Schumann, G., Binder, E. B., Holte, A., de Kloet, E. R., Oedegaard, K. J., Robbins, T. W., Walker-Tilley, T. R., Bitter, I., Brown, V. J., Buitelaar, J., et al. (2014) · European Neuropsychopharmacology
Mental Health and PsychiatryMental Health Research Topics
Cited by 186
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free